Latest News & Features
Americas
US law firm Baker Botts has expanded its Houston office with the addition of IP litigator Nicolas Barzoukas. 1 October 2013
Americas
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations. 30 September 2013
Big Pharma
The annual International Association for the Protection of IP (AIPPI) conference in Helsinki, Finland, assessed the potential problems for pharmaceutical companies trying to brand their medicinal products. 30 September 2013
Americas
Developing new drugs is time-consuming and expensive. DelMar Pharma researches old drugs and establishes new IP around them to streamline the process. LSIPR spoke to chief executive Jeffrey Bacha about the company’s approach. 30 September 2013
Biotechnology
With a track record of successful innovation, Munich is one of the leading lights of European biotech. LSIPR went to visit. 30 September 2013
Americas
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium. 27 September 2013
Americas
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company. 26 September 2013
Big Pharma
The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system. 26 September 2013
Asia
A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students. 25 September 2013
Americas
The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect. 25 September 2013